524564 GAYATRIBI

Gayatri BioOrganics Share Price

 

 

Start SIP in GAYATRIBI

Start SIP

Performance

  • Low
  • ₹12
  • High
  • ₹13
  • 52 Week Low
  • ₹5
  • 52 Week High
  • ₹14
  • Open Price₹12
  • Previous Close₹12
  • Volume8,259

Investment Returns

  • Over 1 Month -0.5%
  • Over 3 Month + 2.9%
  • Over 6 Month + 61.01%
  • Over 1 Year + 77.35%

Smart Investing Starts Here Start SIP with Gayatri BioOrganics for Steady Growth!

Invest Now

Gayatri BioOrganics Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • -117.4
  • PEG Ratio
  • 19.5
  • Market Cap Cr
  • 95
  • P/B Ratio
  • Average True Range
  • 0.65
  • EPS
  • -
  • Dividend Yield
  • 0
  • MACD Signal
  • 0.08
  • RSI
  • 49.78
  • MFI
  • 68.21

Gayatri BioOrganics Financials

Gayatri BioOrganics Technicals

EMA & SMA

Current Price
₹12.06
-0.18 (-1.47%)
pointer
  • Bearish Moving Average 8
  • Bullish Moving Average 8
  • 20 Day
  • ₹12.15
  • 50 Day
  • ₹11.92
  • 100 Day
  • ₹11.18
  • 200 Day
  • ₹9.92

Resistance and Support

12.22 Pivot Speed
  • R3 12.95
  • R2 12.75
  • R1 12.42
  • S1 11.89
  • S2 11.69
  • S3 11.36

Gayatri BioOrganics Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2025-11-13 Quarterly Results
2025-07-29 Quarterly Results
2025-05-28 Audited Results
2025-01-20 Quarterly Results
2024-11-11 Quarterly Results

Gayatri BioOrganics F&O

Gayatri BioOrganics Shareholding Pattern

21.59%
0.65%
0.01%
52.94%
24.81%

Gayatri BioOrganics FAQs

Gayatri BioOrganics share price is ₹12 As on 06 December, 2025 | 23:30

The Market Cap of Gayatri BioOrganics is ₹95 Cr As on 06 December, 2025 | 23:30

The P/E ratio of Gayatri BioOrganics is -117.4 As on 06 December, 2025 | 23:30

The PB ratio of Gayatri BioOrganics is -2.6 As on 06 December, 2025 | 23:30

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23